The main Commission for Drafting the Egyptian Pharmacopoeia headed by Prof. Dr. Aiman El-Khatib, Vice Chairman of the Egyptian Drug Authority (EDA), held its fourteenth meeting at the EDA headquarters, in the presence of Prof. Dr. Mohamed Awad Tag El-Din, Advisor to the President of the Republic for Health and Prevention Affairs.
During the meeting, the newly developed monographs and general chapters of the Egyptian Pharmacopoeia were presented. The latest updates on the EDA's participation, represented by the Egyptian Pharmacopoeia , in the technical review work with the International Pharmacopoeia issued by the World Health Organization (WHO), as well as updates on the technical proficiency testing and the availability of reference materials, were also presented.
It is worth mentioning that the EDA and its active partners have been working on launching the fifth edition of the Egyptian Pharmacopoeia and updating it in line with the latest regulatory systems and international pharmacopoeias. This coincides with the issuance of EDA Chairman's Decree No. 599 of 2024, which allows the use of the fifth edition of the Egyptian Pharmacopoeia and its updates as a reference for registering pharmaceutical and biological products in the Arab Republic of Egypt.
This comes within the framework of national efforts aimed at developing the Egyptian pharmaceutical system and enhancing its position at the local and international levels, in line with the directives of the political leadership, and in cooperation with all relevant parties to ensure the provision of safe, effective, and high-quality medicine.

hashtag#Egyptian_Drug_Authority hashtag#Media_Center hashtag#Egyptian_Pharmaceuticals
hashtag#Pharmacopoeia"